Figure 4
Overall survival (OS) according to del(7q) subgroups. Patients with del(7q) and favorable cytogenetics (t(8;21), inv(16), t(15;17), and t(9;11)) had an OS of 75%. Those with del(7q) without favorable cytogenetics had an OS of 44%.
Overall survival (OS) according to del(7q) subgroups. Patients with del(7q) and favorable cytogenetics (t(8;21), inv(16), t(15;17), and t(9;11)) had an OS of 75%. Those with del(7q) without favorable cytogenetics had an OS of 44%.
